Gastroschisis Outcomes: Presence of Histologic Chorioamnionitis and the Impact on Time to Full Enteral Feeds and Length of Hospital Stay
Objective Despite improvements in our ability for early diagnosis and providing supportive care for infants with gastroschisis, it continues to be associated with long length of stay and morbidity. Intestinal dysfunction secondary to chronic inflammatory insult to exposed bowel is well known; however, little research has been done on the impact of acute inflammation in the perinatal period on intestinal function. This study's aim was to investigate the impact of acute chorioamnionitis on the time to achieve full enteral feeds and length of hospital stay.
Study Design Retrospective chart review of 60 mothers and their infants born with gastroschisis at a Level IV NICU from November 2011 to June 2020 was performed. Infants were divided into two groups based on the presence of histologic chorioamnionitis, and outcomes were compared. The primary outcome was delayed full enteral feeds (full enteral feeds after 28 days of life). The secondary outcomes were differences in their time to achieve full enteral feeds and time to hospital discharge, and prolonged length of hospital stay (discharge after 30 days of life). Univariate and multivariate logistic regression analyses were performed to assess the association between the dependent and the predictor variables.
Result Of the 60 infants enrolled, 23 (38%) had evidence of histologic chorioamnionitis. The median gestational age was 37 weeks. Fifty-four (90%) infants achieved full enteral feeds, with a median time of 24 days. Median length of hospital stay was 31 days. The presence of histologic chorioamnionitis was not associated with delayed full enteral feeds (odds ratio [OR] = 0.79; 95% confidence interval [CI] = 0.14–4.23; p = 0.80) or prolonged length of hospital stay (OR = 0.45; 95% CI = 0.1–0.23; p = 0.32) in the adjusted analysis.
Conclusion Acute placental inflammation during the perinatal period does not impact the infant's time to achieve full feeds or prolong their hospital stay. Larger studies are needed to confirm these findings.
Chronic inflammatory injury to exposed bowel in utero is well known in fetuses with gastroschisis.
Acute inflammatory injury during perinatal period may impact enteral feeding outcomes.
No impact of acute placental inflammation on time to full enteral feeds.
Eingereicht: 02. August 2022
Angenommen: 15. Dezember 2022
Artikel online veröffentlicht:
29. Januar 2023
© 2023. Thieme. All rights reserved.
Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA
- 1 O'Connell RV, Dotters-Katz SK, Kuller JA, Strauss RA. Gastroschisis: a review of management and outcomes. Obstetrical Gynecol Surg 2016; 71 (09) 537-544
- 2 Skarsgard ED. Management of gastroschisis. Curr Opin Pediatr 2016; 28 (03) 363-369
- 3 Jones AM, Isenburg J, Salemi JL. et al. Increasing prevalence of gastroschisis—14 states, 1995–2012. MMWR Morb Mortal Wkly Rep 2016; 65 (02) 23-26
- 4 Kirby RS, Marshall J, Tanner JP. et al; National Birth Defects Prevention Network. Prevalence and correlates of gastroschisis in 15 states, 1995 to 2005. Obstet Gynecol 2013; 122 (2 Pt 1): 275-281
- 5 Overcash RT, DeUgarte DA, Stephenson ML. et al; University of California Fetal Consortium*. Factors associated with gastroschisis outcomes. Obstet Gynecol 2014; 124 (03) 551-557
- 6 Wada M, Kato T, Hayashi Y. et al. Intestinal transplantation for short bowel syndrome secondary to gastroschisis. J Pediatr Surg 2006; 41 (11) 1841-1845
- 7 Torres C, Badalyan V, Mohan P. Twelve-year outcomes of intestinal failure-associated liver disease in children with short-bowel syndrome: 97% transplant-free survival and 81% enteral autonomy. JPEN J Parenter Enteral Nutr 2022; 46 (01) 197-206
- 8 Fatemizadeh R, Gollins L, Hagan J. et al. In neonatal-onset surgical short bowel syndrome survival is high, and enteral autonomy is related to residual bowel length. JPEN J Parenter Enteral Nutr 2022; 46 (02) 339-347
- 9 Guibourdenche J, Berrebi D, Vuillard E. et al. Biochemical investigations of bowel inflammation in gastroschisis. Pediatr Res 2006; 60 (05) 565-568
- 10 Morrison JJ, Klein N, Chitty LS. et al. Intra-amniotic inflammation in human gastroschisis: possible aetiology of postnatal bowel dysfunction. Br J Obstet Gynaecol 1998; 105 (11) 1200-1204
- 11 Frascoli M, Jeanty C, Fleck S. et al. Heightened immune activation in fetuses with gastroschisis may be blocked by targeting IL-5. J Immunol 2016; 196 (12) 4957-4966
- 12 Kim CJ, Romero R, Chaemsaithong P, Chaiyasit N, Yoon BH, Kim YM. Acute chorioamnionitis and funisitis: definition, pathologic features, and clinical significance. Am J Obstet Gynecol 2015; 213 (4, suppl): S29-S52
- 13 Goldstein JA, Gallagher K, Beck C, Kumar R, Gernand AD. Maternal-fetal inflammation in the placenta and the developmental origins of health and disease. Front Immunol 2020; 11: 531543 DOI: 10.3389/fimmu.2020.531543.
- 14 Liu Z, Tang Z, Li J, Yang Y. Effects of placental inflammation on neonatal outcome in preterm infants. Pediatr Neonatol 2014; 55 (01) 35-40
- 15 Bersani I, Thomas W, Speer CP. Chorioamnionitis–the good or the evil for neonatal outcome?. J Matern Fetal Neonatal Med 2012; 25 (1, suppl 1): 12-16
- 16 Mestan K, Yu Y, Matoba N. et al. Placental inflammatory response is associated with poor neonatal growth: preterm birth cohort study. Pediatrics 2010; 125 (04) e891-e898
- 17 Redline RW, Faye-Petersen O, Heller D, Qureshi F, Savell V, Vogler C. Society for Pediatric Pathology, Perinatal Section, Amniotic Fluid Infection Nosology Committee. Amniotic infection syndrome: nosology and reproducibility of placental reaction patterns. Pediatr Dev Pathol 2003; 6 (05) 435-448
- 18 Zani-Ruttenstock E, Zani A, Paul A, Diaz-Cano S, Ade-Ajayi N. Interstitial cells of Cajal are decreased in patients with gastroschisis associated intestinal dysmotility. J Pediatr Surg 2015; 50 (05) 750-754
- 19 Langer JC, Longaker MT, Crombleholme TM. et al. Etiology of intestinal damage in gastroschisis. I: effects of amniotic fluid exposure and bowel constriction in a fetal lamb model. J Pediatr Surg 1989; 24 (10) 992-997
- 20 Srinathan SK, Langer JC, Blennerhassett MG, Harrison MR, Pelletier GJ, Lagunoff D. Etiology of intestinal damage in gastroschisis. III: morphometric analysis of the smooth muscle and submucosa. J Pediatr Surg 1995; 30 (03) 379-383
- 21 Phillips JD, Kelly Jr RE, Fonkalsrud EW, Mirzayan A, Kim CS. An improved model of experimental gastroschisis in fetal rabbits. J Pediatr Surg 1991; 26 (07) 784-787
- 22 Owaki T, Imai K, Miki R. et al. Multiple cytokine analysis in gastroschisis: association with adverse outcomes including fetal brain damage. Cytokine 2021; 138: 155406
- 23 Fasching G, Haeusler M, Mayr J, Schimpl G, Haas J, Puerstner P. Can levels of interleukins and matrix metalloproteinases in the amniotic fluid predict postnatal bowel function in fetuses with gastroschisis?. J Pediatr Surg 2005; 40 (12) 1887-1891
- 24 Abdel-Latif ME, Bolisetty S, Abeywardana S, Lui K. Australian and New Zealand Neonatal Network. Mode of delivery and neonatal survival of infants with gastroschisis in Australia and New Zealand. J Pediatr Surg 2008; 43 (09) 1685-1690
- 25 Kirollos DW, Abdel-Latif ME. Mode of delivery and outcomes of infants with gastroschisis: a meta-analysis of observational studies. Arch Dis Child Fetal Neonatal Ed 2018; 103 (04) F355-F363
- 26 Lopez A, Benjamin RH, Raut JR. et al. Mode of delivery and mortality among neonates with gastroschisis: a population-based cohort in Texas. Paediatr Perinat Epidemiol 2019; 33 (03) 204-212